Luxturna | defytime

Press Releases, News and Articles

FDA panel backs gene therapy for rare form of blindness

Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the...

5 views

Breakthrough Gene Therapy Clinical Trial is the World's First That Aims to Reverse 20 Years of A

Telomerase Gene Therapy treatment of age-related diseases and telomere syndromes does not favor canc

Gene therapy vectors carrying the telomerase gene do not increase the risk of cancer

Dr. Bill Andrews, Ph.D. explains Telomeres, Telomerase and Gene Therapy on CNN Turkey

Dr. Bill Andrews, Ph.D, explains the role of Telomeres and Telomerase in Aging on Korean National Te

Breakthrough Gene Therapy Clinical Trial is the World's First That Aims to Reverse 20 Years of A

Rapidly Aging Cells May Contribute to Shorter Lifespan of Fabry Patients, Study Finds

Shorter Telomeres Increase Risk for MS Disability Progression